PAPER Lutz BM, Peng J

Deep Profiling of the Aggregated Proteome in Alzheimer's Disease: From Pathology to Disease Mechanisms.

Proteomes. 2018 Nov 12;6(4) PubMed: 30424485

PAPER Espargaró A, Pont C, Gamez P, Muñoz-Torrero D, Sabate R

Amyloid Pan-inhibitors: One Family of Compounds To Cope with All Conformational Diseases.

ACS Chem Neurosci. 2019 Mar 20;10(3):1311-1317. Epub 2018 Nov 14 PubMed: 30380841

PAPER Mateos R

Mild cognitive impairment: some steps forward.

Int Psychogeriatr. 2018 Oct;30(10):1427-1429. PubMed: 30426916

PAPER Munro CA

The concept of mild cognitive impairment: a victim of its ubiquity.

Int Psychogeriatr. 2018 Oct;30(10):1423-1425. PubMed: 30426915

PAPER Mukadam N

Improving the diagnosis and prediction of progression in mild cognitive impairment.

Int Psychogeriatr. 2018 Oct;30(10):1419-1421. PubMed: 30426914

PAPER Custodio N, Alva-Diaz C, Morán-Mariños C, Mejía-Rojas K, Lira D, Montesinos R, Herrera-Pérez E, Castro-Suárez S, Bardales Y

Factors associated with depression in patients with Parkinson's disease A multicenter study in Lima, Peru.

Dement Neuropsychol. 2018 Jul-Sep;12(3):292-298. PubMed: 30425793

PAPER McIsaac TL, Fritz NE, Quinn L, Muratori LM

Cognitive-Motor Interference in Neurodegenerative Disease: A Narrative Review and Implications for Clinical Management.

Front Psychol. 2018;9:2061. Epub 2018 Oct 29 PubMed: 30425673

PAPER Riello M, Faria AV, Ficek B, Webster K, Onyike CU, Desmond J, Frangakis C, Tsapkini K

The Role of Language Severity and Education in Explaining Performance on Object and Action Naming in Primary Progressive Aphasia.

Front Aging Neurosci. 2018;10:346. Epub 2018 Oct 30 PubMed: 30425638

Aaron Thome

Houston Methodist Neurological Institute
Houston

Maram Alshuwaymi

Riyadh, Saudi Arabia

Is NfL the New 'N' in A/T/N Classification of Alzheimer’s?

RESEARCH NEWS 2018-11-15 Research News Neurofilament light (NfL) measured in cerebrospinal fluid predicts mild cognitive impairment better than other CSF indicators of neurodegeneration, according to the November 12 JAMA Neurology. Scientists led by Michelle Mielke, Mayo Clinic,

Robert Vassar on Bump in the Road or Disaster? BACE Inhibitors Worsen Cognition

COMMENT We are at a critical juncture for BACE1 inhibition research. The disappointing results of the recent BACE1 inhibitor clinical trials is giving way to the sentiment that BACE1 is too risky a therapeutic target to pursue for AD. This feeling is understandab

Sherlin Gracia

Japan

PAPER Kulas JA, Franklin WF, Smith NA, Manocha GD, Puig KL, Nagamoto-Combs K, Hendrix RD, Taglialatela G, Barger SW, Combs CK

Ablation of amyloid precursor protein increases insulin-degrading enzyme levels and activity in brain and peripheral tissues.

Am J Physiol Endocrinol Metab. 2019 Jan 1;316(1):E106-E120. Epub 2018 Nov 13 PubMed: 30422705

PAPER Fahanik-Babaei J, Baluchnejadmojarad T, Nikbakht F, Roghani M

Trigonelline protects hippocampus against intracerebral Aβ(1-40) as a model of Alzheimer's disease in the rat: insights into underlying mechanisms.

Metab Brain Dis. 2019 Feb;34(1):191-201. Epub 2018 Nov 12 PubMed: 30421246